Selected research
Industry Research
Asenapine Industry Research Report 2026
Market perspective
The global Asenapine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Asenapine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Asenapine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Asenapine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Asenapine include Actavis, Lundbeck A / S, Noven Pharmaceuticals, TargetMol and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Asenapine market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Asenapine Market by Company
Actavis
Lundbeck A / S
Noven Pharmaceuticals
TargetMol
Merck
Asenapine Segment by Type
Patch
Sublingual Tablets
Asenapine Segment by Application
Children
Adult
Asenapine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Asenapine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Asenapine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Asenapine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Asenapine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Asenapine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Asenapine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Patch
- Sublingual Tablets
Applications
- Children
- Adult
Companies covered
- Actavis
- Lundbeck A / S
- Noven Pharmaceuticals
- TargetMol
- Merck
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Asenapine Market Size (2021-2032)
- 2.2.2 Global Asenapine Sales (2021-2032)
- 2.2.3 Global Asenapine Market Average Price (2021-2032)
- 2.3 Asenapine by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Patch
- 2.3.3 Sublingual Tablets
- 2.4 Asenapine by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Children
- 2.4.3 Adult
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Asenapine Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Asenapine Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Asenapine Revenue of Manufacturers (2021-2026)
- 3.4 Global Asenapine Average Price by Manufacturers (2021-2026)
- 3.5 Global Asenapine Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Asenapine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Asenapine, Product Type & Application
- 3.8 Global Manufacturers of Asenapine, Established Date
- 3.9 Global Asenapine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Actavis
- 4.1.1 Actavis Company Information
- 4.1.2 Actavis Business Overview
- 4.1.3 Actavis Asenapine Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Actavis Asenapine Product Portfolio
- 4.1.5 Actavis Recent Developments
- 4.2 Lundbeck A / S
- 4.2.1 Lundbeck A / S Company Information
- 4.2.2 Lundbeck A / S Business Overview
- 4.2.3 Lundbeck A / S Asenapine Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Lundbeck A / S Asenapine Product Portfolio
- 4.2.5 Lundbeck A / S Recent Developments
- 4.3 Noven Pharmaceuticals
- 4.3.1 Noven Pharmaceuticals Company Information
- 4.3.2 Noven Pharmaceuticals Business Overview
- 4.3.3 Noven Pharmaceuticals Asenapine Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Noven Pharmaceuticals Asenapine Product Portfolio
- 4.3.5 Noven Pharmaceuticals Recent Developments
- 4.4 TargetMol
- 4.4.1 TargetMol Company Information
- 4.4.2 TargetMol Business Overview
- 4.4.3 TargetMol Asenapine Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 TargetMol Asenapine Product Portfolio
- 4.4.5 TargetMol Recent Developments
- 4.5 Merck
- 4.5.1 Merck Company Information
- 4.5.2 Merck Business Overview
- 4.5.3 Merck Asenapine Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Merck Asenapine Product Portfolio
- 4.5.5 Merck Recent Developments
5 Global Asenapine Market Scenario by Region
- 5.1 Global Asenapine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Asenapine Sales by Region: 2021-2032
- 5.2.1 Global Asenapine Sales by Region: 2021-2026
- 5.2.2 Global Asenapine Sales by Region: 2027-2032
- 5.3 Global Asenapine Revenue by Region: 2021-2032
- 5.3.1 Global Asenapine Revenue by Region: 2021-2026
- 5.3.2 Global Asenapine Revenue by Region: 2027-2032
- 5.4 North America Asenapine Market Facts & Figures by Country
- 5.4.1 North America Asenapine Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Asenapine Sales by Country (2021-2032)
- 5.4.3 North America Asenapine Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Asenapine Market Facts & Figures by Country
- 5.5.1 Europe Asenapine Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Asenapine Sales by Country (2021-2032)
- 5.5.3 Europe Asenapine Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Asenapine Market Facts & Figures by Country
- 5.6.1 Asia Pacific Asenapine Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Asenapine Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Asenapine Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Asenapine Market Facts & Figures by Country
- 5.7.1 South America Asenapine Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Asenapine Sales by Country (2021-2032)
- 5.7.3 South America Asenapine Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Asenapine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Asenapine Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Asenapine Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Asenapine Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Asenapine Sales by Type (2021-2032)
- 6.1.1 Global Asenapine Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Asenapine Sales Market Share by Type (2021-2032)
- 6.2 Global Asenapine Revenue by Type (2021-2032)
- 6.2.1 Global Asenapine Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Asenapine Revenue Market Share by Type (2021-2032)
- 6.3 Global Asenapine Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Asenapine Sales by Application (2021-2032)
- 7.1.1 Global Asenapine Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Asenapine Sales Market Share by Application (2021-2032)
- 7.2 Global Asenapine Revenue by Application (2021-2032)
- 7.2.1 Global Asenapine Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Asenapine Revenue Market Share by Application (2021-2032)
- 7.3 Global Asenapine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Asenapine Value Chain Analysis
- 8.1.1 Asenapine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Asenapine Production Mode & Process
- 8.2 Asenapine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Asenapine Distributors
- 8.2.3 Asenapine Customers
9 Global Asenapine Analyzing Market Dynamics
- 9.1 Asenapine Industry Trends
- 9.2 Asenapine Industry Drivers
- 9.3 Asenapine Industry Opportunities and Challenges
- 9.4 Asenapine Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst